logo
  

Pre-market Movers: AVEO, RMED, GRNA, ARC, INPX…

us pre market 053119 18oct22 lt

The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.05 A.M. ET).

In the Green

AVEO Pharmaceuticals, Inc. (AVEO) is up over 38% at $14.47
Ra Medical Systems, Inc. (RMED) is up over 38% at $7.54
GreenLight Biosciences Holdings (GRNA) is up over 14% at $2.35
ARC Document Solutions, Inc. (ARC) is up over 13% at $2.55
Pennsylvania Real Estate Investment Trust (PEI) is up over 11% at $2.98
fuboTV Inc. (FUBO) is up over 9% at $4.44
Ternium S.A. (TX) is up over 8% at $30.00
AG Mortgage Investment Trust, Inc. (MITT) is up over 8% at $4.13
Clough Global Opportunities Fund (GLO) is up over 7% at $5.99
Innovative Eyewear, Inc. (LUCY) is up over 7% at $2.04
Vertical Aerospace Ltd. (EVTL) is up over 5% at $10.24
CEL-SCI Corporation (CVM) is up over 5% at $3.49

In the Red

Inpixon (INPX) is down over 12% at $7.97
Dragonfly Energy Holdings Corp. (DFLI) is down over 11% at $8.48
Polaris Inc. (PII) is down over 5% at $92.04

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
RELATED NEWS
Follow RTT